Arca
Skip to content
Tools
Tools

fos

Compounds containing phosphorus, many of them pesticides or worm treatments.

  • Drugs containing fos: 42
  • Approved somewhere: 12
  • With a US drug page: 10

What it means

Stem from WHO's stem book, 2024; description by Arca
Stem
fos
Class
Compounds containing phosphorus, many of them pesticides or worm treatments
Most common targets
DNA (5), TACR1 (2), POL (1), DNA polymerase catalytic subunit (1), MURA (1), ACE (1), Sodium channel alpha subunit (1), SYK (1)

Drugs that carry it

Approved and clinical-stage drugs in ChEMBL whose names containing fos or one of its sub-stems, matched by spelling; those with a US drug page link to it.
Acts on
FosamprenavirApprovedPOLHuman immunodeficiency virus type 1 protease inhibitor
FoscarnetApprovedDNA polymerase catalytic subunitHuman herpesvirus 1 DNA polymerase inhibitor
FosdenopterinApproved—Unknown
FosfomycinApprovedMURAUDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
FosinoprilApprovedACEAngiotensin-converting enzyme inhibitor
FosphenytoinApprovedSodium channel alpha subunitSodium channel alpha subunit blocker
FostamatinibApprovedSYKTyrosine-protein kinase SYK inhibitor
FospropofolPhase 3—Unknown
FosaprepitantApprovedTACR1Neurokinin 1 receptor antagonist
FosnetupitantApprovedTACR1Neurokinin 1 receptor antagonist
FostemsavirApprovedENVEnvelope polyprotein GP160 inhibitor
FosbretabulinPhase 3TubulinTubulin inhibitor
FosfocreatinePhase 3——
Fosgemcitabine palabenamidePhase 3——
FoslevodopaPhase 3ADRB1Beta-1 adrenergic receptor agonist
FosmanogepixPhase 3GWT1GPI-anchored wall transfer protein 1 inhibitor
FosmetpantotenatePhase 3—Phosphopantothenate replacement therapy
FosmidomycinPhase 3DXR1-deoxy-D-xylulose 5-phosphate reductoisomerase, apicoplastic inhibitor
Fosclevudine alafenamidePhase 2——
FosdagrocoratPhase 2NR3C1Glucocorticoid receptor modulator
Fosdesdenosine sipalabenamidePhase 2——
FoselutoclaxPhase 2——
FosgonimetonPhase 2——
FosigotifatorPhase 2——
FoslinanibPhase 2——
FosravuconazolePhase 2ERG11Cytochrome P450 51 inhibitor
FoscarbidopaPhase 1DDCDOPA decarboxylase inhibitor
FosciclopiroxPhase 1——
Fosifloxuridine nafalbenamidePhase 1——
Fostroxacitabine bralpamidePhase 1——
Fosfonet———
IfosfamideApprovedDNADNA inhibitor
CanfosfamidePhase 3DNADNA disrupting agent
GlufosfamidePhase 3DNADNA disrupting agent
PalifosfamidePhase 3DNADNA cross-linking agent
TrofosfamidePhase 3——
EvofosfamidePhase 2DNADNA inhibitor
PerfosfamidePhase 2——
MafosfamidePhase 1——
MiltefosineApproved—Unknown
PerifosinePhase 3——
IopofosinePhase 2——

Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.